Effects of cervical NAGs on neck muscles in COPD patients
Effects of Cervical Nags on Accessory Muscles in Patients With Copd
This study is testing if a special neck movement can help people with COPD feel less muscle tightness and pain while breathing.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Islamabad, Federal) |
| Trial ID | NCT06736145 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the impact of cervical natural apophyseal glides (NAGs) on accessory muscles, particularly the sternocleidomastoid and scalene, in patients with chronic obstructive pulmonary disease (COPD). By applying these gliding movements, the research seeks to improve spinal mobility and reduce muscle tightness and pain associated with labored breathing. The study will include patients with moderate to severe COPD who are clinically stable, while excluding those with cervical spine or cardiac diseases. The research is particularly focused on the population in Pakistan, where further exploration of this approach is warranted.
Who should consider this trial
Good fit: Ideal candidates are individuals with a history of moderate to severe COPD who are clinically stable.
Not a fit: Patients with pre-existing cervical spine disease, cardiac conditions, or severe respiratory co-morbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance muscle flexibility and reduce pain for COPD patients, improving their quality of life.
How similar studies have performed: While there is evidence supporting the benefits of apophyseal glides in improving spinal mobility, this specific application in COPD patients is relatively novel and under-researched.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Registered with history of moderate (II) to severe (III) grade COPD (for a minimum of 1 year) will be included in the study. * Patients who are clinically stable. Exclusion Criteria: * Patients who have any pre-existing cervical spine disease. * Patients who have any cardiac disease. * Other respiratory co-morbidities * Patients who have severe dizziness or coughing
Where this trial is running
Islamabad, Federal
- Pakistan institute of medical sciences — Islamabad, Federal, Pakistan (Recruiting)
Study contacts
- Principal investigator: Asmar Fatima, MSOMPT — Riphah International University
- Study coordinator: Asmar Fatima, MS-OMPT
- Email: asmar.fatima@riphah.edu.pk
- Phone: 03336195644
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.